secwatch.observer — SEC 8-K summary
======================================

Issuer:     RIGEL PHARMACEUTICALS INC (RIGL)
CIK:        0001034842
Form:       8-K
Filed at:   2026-05-20T20:10:19+00:00
Accession:  0001034842-26-000041
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Rigel shareholders approve equity plan amendments adding 860K shares; re-elect directors
--------------------------------------------------------------------------------

- Stockholders approved amendment to 2018 Equity Incentive Plan, adding 500,000 shares.
- Stockholders approved amendment to 2000 ESPP, adding 360,000 shares.
- Directors Alison Hannah, Walter Moos, Raul Rodriguez re-elected with >86% votes cast in favor.
- Advisory say-on-pay approved with 9,013,480 votes for (87.5% of votes cast).
- Ratification of Ernst & Young as FY2026 auditor passed with 12,590,773 votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1034842/000103484226000041/0001034842-26-000041-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1034842/000103484226000041/rigl-20260514.htm
  HTML page:      https://secwatch.observer/filing/0001034842-26-000041

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer